Oregon lawmakers to vote on universal healthcare, lower drug prices

Oregon lawmakers are taking another pass at universal healthcare for the residents of state, according to a new report by The Register Guard. If SB 770 is passed, it will create a committee that would “design, implement and run a state health insurance plan.” 

Oregon is not the only state in the union to push for universal healthcare. A legislative committee in California heard proposals about how to achieve the goal of universal healthcare in the state. 

More than 35 state-level legislators are sponsors of the bill, which will allow residents who work full-time in Oregon to pay income tax, while simultaneously buying into the program. Financing of the program would come from a reserve held separately from the state’s general fund.

“This is just one step on the way to offering affordable healthcare to all Oregonians,” state Rep. Julie Fahey (D-Eugene), a chief co-sponsor of the bill, told The Register Guard.

Another high-profile bill the state legislature will vote on is SB 409—which will create a state committee to import drugs from Canada and offer them at a lower price to state pharmacies. The pharmacies will then pass those savings on to patients.

“I think that everyone believes that prescription drug prices are a huge problem,” said state Sen. Elizabeth Steiner Hayward (D-Portland).

To read the story, click the link below.

""

As a senior news writer for TriMed, Subrata covers cardiology, clinical innovation and healthcare business. She has a master’s degree in communication management and 12 years of experience in journalism and public relations.

Around the web

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.